Process for producing steroid spirooxazolidines or their stereoisomers

专利摘要:
The invention relates to novel spirooxazolidines represented by the formula I <IMAGE> (I) wherein R1 is alkyl having from 1 to 4 carbon atoms; R2 is hydrogen, alkyl having from 1 to 4 carbon atoms, alkenyl having from 1 to 4 carbon atoms, or dialkylphosphinoxymethyl having in the alkyl moiety from 1 to 3 carbon atoms each; Z is one of the groups represented by the formulae III to XIV as subsequently defined therein.
公开号:SU931109A3
申请号:SU782590453
申请日:1978-03-13
公开日:1982-05-23
发明作者:Шойом Шандор；Полди Лайош；Силадьи Каталин；Шефер Инге；Сонди Элеонора；Борвенди Янош；Херманн Иллона
申请人:Рихтер Гедеон Ведьесети Дьяр Рт (Инопредприятие)；
IPC主号:

专利说明:

Example 2, AHflpocT-t-eH, 3-one-175-spiro-5- (2-oxo-3 methyloxazolidine). Method A. A mixture of 9 g of androst-5-en-3 (1-ol-175. Spiro-5- (2-oxo-3-methyloxazolidine) obtained in example 1, 10.2 g of aluminum isopropylate and 52 ml of cyclohexanone bale t in 200 ml of dry toluene for 13 hours. After cooling, the reaction mixture is extracted with three 50 ml portions of hydrochloric acid, 15 ml of water and 15 ml of saturated sodium carbonate and water. The organic phase is dried, evaporated and the resulting the oily residue is triturated with isopropyl ether. The crystalline product obtained is washed with isopropyl ether and As a result of recrystallization of the crude product from ethyl acetate, k is obtained, 2 g of pure compound. mp. 189 ° C; oCJ + kk ° (, S, chloroform). If the crude product is recrystallized from methanol with the addition of isopropyl ether, then the melting of the product obtained in the example is equal to. Method B. A mixture of 2.03 g of M-ethoxycarbonyl-17 x methyl aminomethylandrost-B-en-3p-ol, 5.2 ml of c-hexanone and 2.0 g of aluminum isopropyl 30 ml of dry toluene is boiled for 7 hours. The reaction mixture is extracted with 5% hydrochloric acid solution. The organic phase is shaken until neutral with a saturated aqueous solution of sodium hydrogencarbonate and water, dried and evaporated. After trituration of the oily residue with isopropyl ether, 1.08 g of crude an) is obtained; growth-en-3-one-175-h: pyro-5 - (2-oxo-3-methyloxazolidine). T. pl. (after recrystallization from ethyl acetate) 188-189 C; (, 5, chloroform). PRI me R. 3 3 (-0 xyandrost 5-ene-175-spiro-5 - (2-oxo-3-allyl oxazolidine). Step A. The procedure described in example 1 is followed by stage A, however, 9 is taken as the starting compound; 06 g of Cd-oxy-Drost-5-en-175-spir oxirane and 25 ml of allyl 96 amine and 0.90 g of α-toluene sulfonic acid are used, and after recrystallization from ethyl acetate, 7.72 g of 17ot-allylaminomethylandrost-5 en-3/5 , Og, m20 17 (L-Diol. So pl., 5, chloroform). Stage B., According to the method described in example 1, stage B, however, starting from 7/18 g 17 ° C-allylaminomethylandrost-5 en-3 17 (2 -diol and recrystallization of ne looking for a crude product from ethyl acetate with the addition of isopropyl ether, 6.92 g of N-ethoxycarbo-1L-.17 (L-allylaminomethylandrost-5-enZr, 17 (3-dyl. T. PL8 ° C; I2O -57 ° C (, 5, chloroform.) Step C. The ring closure of the indicated N-ethoxycarbonyl-17 ° C-allylaminomethyl compound is carried out as described in Example 1, Step C, resulting in a compound as desired. Mp. 259 ° C; o, 5, chloroform). PRI me R ij. Z-Z-Oxyandrost-5-ene-175-spiro-5- (2-oxo-3-isopropyl-7 oxazolidine). Stage A. According to the method described in Example 1, Stage A, starting from 6.0 g of Sp-oxyandrost-5-ene-175-spirooxrane and 17 ml of isopropylamine and using 0.60 gp-toluenesulfonic acid as catalyst, 7 are obtained 11 g of 17O1; -isopropylaminomethylandrost-5-en-3 (, 17 (3-diol. After recrystallization from ethyl acetate by adding an equivalent volume of H-hexane, the product melts at 112-113c; i: oC3 j ° -76, (5, chloroform). Stage B. Starting from the product obtained from stage A and according to the method of the example .. 1, stage B, H-1 is obtained. Sicarbonyl-17 7 -diol, which, after recrystallization from ethyl acetate, melts at C; l. (, 5, chloroform). Step C. The closure of the ring of the indicated compound is carried out as described in Example 1, step C, resulting in the desired compound.
79
which, after recrystallization from ethyl acetate, melts at 222-223 ° C; -117 ° (, 5, chloroform).
Example 5 3 (L-Fluoroidrost-5-E-175-spiro-5- (2-oxo-3-methyloxazolidine).
Stage D.
To a stirred suspension, 8.85 g 3 (1-fluorostrost-5-en-17-one and 14), about 10 grams of trimethylsulfonium iodide in 100 ml of dry dimethylformamide, add 8.50 g of potassium tert-butylate in a quarter of an hour. The resulting mixture stirred for 2.5 h and then poured into 1700 ml of ice water. The precipitated crystals are filtered and washed with water until neutral. After recrystallization of the valuable product from methanol, 7.15 g of pure 3 is obtained (L-fluorostrost 5-en-1 75-spiroksirana. Tpl OS -9 (, 5, chloroform)
Stage B.
According to the method described in Example 1, Stage A, Outcome of 6.1 g 3 (L Fluorodrost-5-ene-175-Spirooxira and 50 ml of liquid methylamine and using 0.60 gp toluene sulfonic acid as a catalyst, after recrystallization from methanol 5.1 g of 3ft-fluoro-17 are obtained (1-methylaminomethylandrost-5-ene-17p-ol. mp. 175 ° C; Y -1 O0- (, 5, chloroform).
Stage C.
According to the method described in Example 1, Step B, however, starting from 3p-fluoro-1-methylaminomethylandrost-5-ene-17 3-ol, obtained in this step B, the corresponding N-ethoxycarbonyl derivative is obtained. After recrystallization from the methanol product melts at 172 ° C; OBD -77 ° (, 5, chloroform).
Stage D.
2.10 g of 3-fluoro-M-ethoxycarbonyl 1.-Methylaminomethylandrost-5-ene-17E-ol, prepared as for stage C, is treated according to the method described in example 1, step C, and after recrystallization from isopropyl ether, 1.79 g of the desired compound are obtained. M.p. W D -127 ° (, 5, chloroform).
Example 6 Androst-en-3-one-175-spiro-5- (2-oxo-3-allyloxazolidine).
2.16 g of M-ethoxycarbonyl-17.-allylaminomethyleneandrost-5-ene-Zr, 17p-diol
98
prepared as indicated in example 3, step B, is oxidized in accordance with the method described in example 2, step B. 1.3 g of crude product are obtained. After recrystallization from ethyl acetate and addition of isopropyl ether, 1 g of product is obtained. M.p. 13X32C; S +7.2 (, 5, chloroform).
Example 7 Androst-en3 he-175-spiro-5- (2-oxo-3-isopropyl oxazolidine).
2.1 g of M-ethoxycarbonyl-17c1 -isopropylaminomethylene-5-ene-3 (3, 17 / -Diol, obtained in accordance with Example 1, in Step B, is oxidized as described in Example 2, Step B. The resulting the product is recrystallized from ethyl acetate with the addition of isopropyl ether, resulting in a yield of 0.90 g of the desired compound. mp 177-179 ° C; v (5, chloroform).
Example P 8.Andproct-A, 6-dien-3-on17S-spiro-5- (2-oxy-s-methylloxazolidine) Method A.
A mixture of 3.15 g androst-4-en-3-one1 75-spiro-5- (2-oxo-3-methyl-oxazolidine), obtained as described in example 2, and 13 g of chloranil in k ml of tert.- butanol is boiled for 3 hours with stirring. The reaction mixture is allowed to cool to room temperature, filtered and the resulting filtrate is evaporated. The residue is dissolved in chloroform, the insoluble is filtered off and the chlorophoric solution is extracted with four portions of a 5% solution of sodium hydroxide, 12 ml each, and then with two portions of water, 10 ml each, and then dried with magnesium sulphate. The extract obtained is concentrated, and the residue is taken up in a crystalline state by trituration, whereby 2.75 g of crude product is obtained. After recrystallization from ethyl acetate, repeated twice, the product obtained is melted at 212-213 ° C; -20.3 (, 5, chloroform).
and to -2v2all
Method B.

权利要求:
Claims (1)
[1]
To a stirred suspension of 7.18 g of androst-5-en-zp-ol-17-5-spiro-5- {2oxo-3-methyloxazolidine), prepared according to the method described in example 1, and 0.28 g of powdered dry sodium acetate in 70 ml of dry tetrahydrofuran is added dropwise a mixture of 3.2 g of bromine and 10 ml of glacial acetic acid.  At 10 ° C, several minutes after the steroid has been dissolved, a yellow precipitate can be observed.  After 0.5 h, with stirring, the reaction mixture was poured onto 900 ml of ice-cold water, left to stand for a while, and the precipitate was filtered off.  The crude product is placed in too ml of glacial acetic acid, and the resulting suspension is heated to 6of, 6.56 g of sodium bichromate containing 2 mol of crystallization water in 20 ml of ice acid, is heated to 80 ° C and added to this suspension at stirring.  The resulting dark solution is stirred and cooled for half an hour and poured into 800 ml of ice and water.  The precipitated crystalline substance is filtered and washed with water.  9.5 g of the crudely prepared dibromoketone is dissolved in 100 ml of dimethylformamide, 9.5 g of lithium bromide and 9.5 g of lithium carbonate are added.  The resulting mixture was boiled for 1.5 hours with stirring.  The crude product is poured into ice water and recovered by filtration.  The yield (after recrystallization from ethyl acetate using wood charcoal, while providing) is ≈ 32 g.  T. square  212 ° C; -21 ° (, 5, chloroform).  Example 9  Androst-1, CH-dien 3-on-17S-thio-5- (2-oco-3-methyl. okkazolidin).   2.18 g of androst-en-3-one-17S-spiro-5- {2-oxo-3-methyloxazolidine) prepared according to example 3, are boiled in 3b ml of dry dioxane with 1.5 g of 2,3-dichloro- 5,6-dicyano-1, -benzohino on for tO h  The mixture was allowed to cool to room temperature, the precipitate was filtered off and the resulting filtrate was evaporated.  The evaporated residue is dissolved in 70 ml of dichloromethane and extracted with 5 portions to 10 m of 1% sodium hydroxide solution and thereafter with three 10 ml portions of water.  The dichloromethane solution is dried, passed through silica gel and evaporated to give 1.5 g of a yellow crystalline product.  After recrystallization from ethyl acetate (recrystallization is carried out twice), 0.2 g of pure product is obtained.  T. square    (, 5, chloroform); ° nm.  Example 10  Androst-1. tjS-trien-3-one-175-spiro-5- (2-oxo-Zmetiloksazolidin).  A mixture, 28 g 3 (3-oxyandro, st-5-en175-spiro-5- (2-oxo-3-methyloxazolidine) obtained in example 1, and 8.15 g of 2,3-dichloro-5,6- dicyano-1, "benzoquinone in 120 ml of dioxane is boiled for 80 h.  The reaction mixture was worked up as described in Example 9, except that the dichloromethane solution of the crude product was passed through neutral alumina.  The product obtained is recrystallized from ethyl acetate, whereby 0.90 g of the desired compound is obtained.  T. square  22322g ° C; And 1 (, 5, xlopofop L 298, 221 nm.  Example 11  1Zp-ethyl-3-methoxygon-2, 5- (Yu) -diene-175-spiro-5- (2-oxo-3-methyloxazolidine).  Method A.  Stage A.  To a stirred suspension of kk, 0 g of 1 3 (5-ethyl-3-methoxygon-2.5 (10) dien17-one) 118.8 g of trimethyl sulfonium iodide in 660 ml of dry dimethylformamide are added g of potassium tert-butylate in half an hour.  Stirring is continued for 2 hours.  Then, the reaction mixture was poured into ice water, and the precipitated white crystalline product was filtered and washed with water.  The crude product is dried, boiled with two times the volume of methanol and filtered while hot.  The result is 3.1 g of 13fi ethyl-3-methoxygon-2,5 (10) -diene-17S spirooxan with t. square  183 ° C.  To obtain an analytical grade compound, about 1 g of the crude product is recrystallized from a 30-fold volume of ethyl acetate.  T. square  the compound obtained is 187189 ° C; wasps + 106 ° (, 5, chloroform). i Stage B.  In accordance with the procedure described in example 1, step A, however, a descent from 30 g of the obtained 13p-ethyl 3-methoxy-2, 5 (10) -diene-175-spiroxrane and 90 ml of liquid methylamine using 3 g of p-toluenesulfonic acid in as a catalyst, 26 g of 13 | 1-ethyl-3-methoxy-17ob-methyl11 are obtained.  aminomethyl-2.5 × 10) -diene-17E Ola For analytical purposes, about 1 g of the crude product is recrystallized) from ethyl acetate, resulting in a product with m. square  188: -189 C; +67 (, 5, chloro. forms).  Stage C.  13.5 g of 13 5-ethyl-3-methoxy-17o: -methylaminomethylgonadiene-17 (L-ol obtained in stage B, is reacted with pyrogonal diethyl ester, as described in example 1, stage B.  The product obtained is recrystallized from methanol, as a result of which N-e-Yoxycarbonyl-13p-ethyl-3-methoxy-176-methylaminomethyl-2-5 (10) diene-17 5-o l is obtained.  Yield 11 g, t. square  137 ° C; D + 25 ° (, 5, chloroform).  Stage D.  A solution of IjOt g N-ethoxycarbonyl-13 1-these -3-methoxy-17o-methylaminomethyl-2, 5 (10) -diene-17p) -ol in 15 ml,.  ethanol containing 0.5 g of potassium hydroxide is boiled for 1 hour.  The reaction mixture is worked up in accordance with Example 1, Step C, and the product obtained is recrystallized from ethyl acetate to obtain 0.60 g of 13 p | -ethyl-3-methoxygon-2.5 (10) -diene175-spiro-5- (2 -oxo-3-methyloxazolidine).  T. square  207 ° C; + 17 ° (, 5, chloroform).  Example 12  13 / -9tile-4-en-3-one-175-spiro-5- (2-oxo-3-methyloxazolidine).   , 0 g of 13p-ethyl-3-methoxygon-2, 5 (10) -diene-175-spiro-5- (2-oxo-3-methyloxazolidine), obtained in accordance with example 11, are mixed in a mixture with AO ml of methanol 4 m water and 2 ml of concentrated hydrochloric acid for 1 h at.  The reaction mixture is evaporated, then the residue is placed in water.  The resulting crystalline substance is filtered off, dried and recrystallized from ethyl acetate.  2.5 g of pure compound are obtained. square  192 ° C; oC1 -ifl4 ° (, 5 chloroform).  Example 13  13p-ethyl-5 (10) -en-3-one-175-spiro-5- (2-oxo-3-methyloxazolidine).  The mixture, 2 g of malonic acid, 70 ml of water and 170 ml of ethanol are heated and 912 suspensions of 7, t of 13p-ethyl-3-methoxygon-2, 5 (10) -diene-175-spiro-5 are added with stirring {2-oxo-3-methyl-oxazolidine), obtained as described in example 11, in 80 ml of ethanol.  In a few minutes, a solution is obtained, which is then maintained at 70 ° C. for a further 20 minutes.  200 ml of a saturated solution of sodium hydrogencarbonate and then COOO ml of water are added dropwise to the solution while cooling with ice, the precipitate formed is filtered and washed with water, resulting in 6.8 g of the desired compound with m. square  1b2-1b6 S.  An analytical sample is obtained by dissolving about 1 g of the substance in cold acetone and adding isopropyl ether.  The crystals precipitated upon cooling are filtered off.  The resulting product melts at {OL + 51 ° (with chloroform).  Example 1  13 | 5-Ethylgonate 4, 9 (TO) -diech-3-one-175-spiro-5- (2oxo-3-methyloxazolidine).  To a stirred solution of 11.1 g of 1315-ethyl-gona-5- (10) -en-3-one-175-spiro-5- (2-oxo-3-methyloxazolidine) obtained in example 13, in 50 ml of dry pyridine is added dropwise A solution of 10 g of pyridineperbromide in 50 ml of pyridine is added in 0 min at 20 s.  The reaction mixture is then stirred for 3.5 hours at room temperature and poured into 1 l. Oily water The liquid crystallizes when scraping.  After recrystallization of 8.38 g of the crude product from ethyl acetate, 6.3 g of the pure compound are obtained.  T. square  165 167С; 1 2b5 {0.5, chloroform); E1anoA -, A max 301 nm.  PRI me R 15.  13 (-Etil-3methoxygon-1, 3.5 (10) -triene-175-alcohol-5- (2-oxo-3-methyloxazolidine).  Starting from 1.78 g of 13-ethyl-3-methoxygon-2, 5 (10) -diene-1 7S-spiro-5 (2-oxo-3-methyloxazolidine) obtained in example 11, and in accordance with the procedure described in example I, after recrystallization of the crude product from ethyl acetate, 1.19 g of pure product are obtained with m. square  197-193 C; -29 ° {s (5, chloroform); Udgs 276, 28k nm.  Example 16  13p-Ethylgon, 9 (10) -11-trien-3-one-175-spiro-5- (2-oxo-Z-methyloxazolidine).  13 To a stirred solution of 13p-ethylgon-, 9 (10) -diene-3-one-175-spiro-5- (2-oxo-3-methyloxazolidine prepared according to example I, in 35 ml of dry ethanol at room temperature 0.5 g of pyrrolidine under nitrogen atmosphere. After the suspension, the suspension is cooled in an ice-water bath and then washed with ice-cold methanol. 2.6B gamine compounds are obtained.  To a stirred suspension of the indicated enamino compound with 5 ml of methanol and 2.5 ml of water are added 1, 20 ml of acetic acid in a nitrogen atmosphere at 20c.  After 2 hours, another portion of water (25 ml) is added with stirring and stirring is continued for another 12 hours.  The reaction mixture is diluted with another 100 ml of water, the precipitate is filtered off and washed with water.  The obtained crude 13 (5 ethylgon-5 (10), 9 (11) -diene-3-one-17S-spiro-5- (2-oxo, -3-methyloxazolidine) is dried, dissolved in acetone at room temperature, discolor with charcoal, concentrate to Vt of its original volume and finally dilute with isopropyl ether.  The precipitated I, g 13Y ethylgone-5- (S), 9 (11) -diene-3-one 175-spiro-5- (2-oxo-3-methyloxazolidine) melts at 17-17 ° C.  To a solution of O, E of this compound in 10 ml of dry dioxane, a solution of 0.62 g of 2-3-dichloro-5,6-dicyano-1 is added. tbenzoquinone in ml of dioxane in nitrogen atmosphere.  The reaction mixture is stirred for 2 hours in the dark, then filtered and the dioxane filter is evaporated.  The residue was dissolved in dichloromethane and the resulting solution was extracted with a 1% aqueous solution of sodium hydroxide and then with water.  After drying and evaporation of the extract, a yellow oily substance is obtained, which crystallizes with trituration with Isopropyl ether, to obtain 0.3 g of crude 13-ethylgon-, 9 (10), 11-trienZ-1-75-spiro-5- ( 2-oxo-3-methyloxazolidine), which has been recrystallized from ethyl acetate to 225-226 ° C; about L ° -83 (, 5, chloroform); 335, 235 nm. Example 17.  13 / -Etilgone, 6-dien-3-one-175-spiro-5- (2-oxo 3-methyloxazolidine).  9 1 T 13 | 3-ethylgona-4-en-3-one-175spiro-5- (2-oxo-3-methyloxazolidine) is dissolved in 20 ml of dry dioxane, 1 ml of orthoformate ethyl acid and 0.1 ml of solution , obtained from 0.35 ml of concentrated sulfuric acid and 7 ml of dry dioxane, is added to the solution, which is stirred for one hour at room temperature, then two drops of pyridine are added and the mixture is poured into 200 ml of ice water.  The precipitate formed is filtered off, washed with water and dissolved in 7.3 ml of acetone.  Then, 0.39 g of chloranil is added and the solution is stirred at room temperature for 1.5 hours in the dark.  It is then evaporated, and the residue is dissolved in 200 ml of dichloromethane.  The dichloromethane solution is dried, passed through neutral alumina and evaporated.  After recrystallization of the evaporated residue from ethyl acetate, 0.17 g of pure product is obtained.  T. square  2b7-2b8 ° C, Соср: -E2 °, 5, chloroform) 282 nm.  Example 18  3-Methoxyestra1, 3.5 (10), 9 (11) -tetraen-17S-spp65- (2-oxo-3-methyloxazolidine).  Stage A.  In accordance with the procedure described in Example 11, Method A, Stage A, starting from 3-methoxyester1, 3.5 (10), 9 (11) tetraen-17/5-she, receive 3-methoxyestra-1,3,5 (10), 9 (11) -tetraen-175-spirooxirane, which, after recrystallization from methanol, melts at l42 ° C; | oC3 + 12b ° (, 5, chloroform).  Stage B.  In accordance with the procedure described in Example 11, Method A, Stage B, out of 80 g of 3-methoxy-estra1, 3.5 (10), 9 (11) -tetraen-175-spirooxrane, 3.0 g of 3- methoxy17o methylaminomethylene-1, 3.5 (10), 9 (11) -tetraen-17 | 5-ol with t. square  13,135 ° C; оС120 + 90 ° (, 5, chloroform) Stage C.  In accordance with the procedure described in Example 1, Step B, however, a descent from 3.0 g of 3-methoxy-17 ° C methylminomethyl-1, 3.5 (10), 9 (11) etraene-17 (5-ol, the corresponding N-carbethoxy derivative is obtained.  The crude product is converted to the appropriate spiro compound in ethanol according to the method described in Example 1, Step C.  The product obtained is recrystallized from methanol to give 2.21 g of the desired compound with m. square  187C; O + 10 ° (, 5, chloroform).  Example 19  3-0xy-5p, 19 Cycloandrost-6-en-175-spiro-5 2-oxo-3-methyloxazolidine).  Stage A.  To a suspension of S, t7 g of Cd-acetoxy5 (19-Cycloandrost-6-ene-17-one and 6.8 g of trimethylsulfonium iodide in 53 m of dry dimethylformamide, 5.6 g of potassium tert-butanol are added during 10 minutes.  The resulting mixture was stirred for another 15 minutes and then poured into ice water.  The precipitated substance is filtered off, washed until neutral with water and dried.  After recrystallization from ethyl acetate, 2.147 g of 3p-oxy-5p, 19-cycloandrost-6-ene-175-spirooxirane with m are obtained. square  18018lOc; Co l ° -15.70 (, 5, chloroform).  Stage B.  In accordance with the procedure described in example 1, step A, starting from 2.7 g of Sp-hydroxy-5p, 49-Cycloandrost-6-ene-175-spirooxrane, 3, 173-dioxy-17ob 1-methylaminomethyl-5 f are obtained, 19-Cycloandrost-6.  The crude product is recrystallized from ethyl acetate to obtain 1.88 g of pure product with m. square  198-199 ° C; IOL -k3 ° (, 5, chloroform).  Stage C.  1.80 g of 3 - 17-dioxy-17-methylaminomethyl-5, 19-cycloandrost-6-one obtained in Step B, is converted into the corresponding N-ethoxycarbonyl compound in accordance with the procedure described in Example 1, Step B, and After extraction of the crude product is converted to Sp-hydroxy-5p, 19-Cycloandrost-6-ene-175-spiro-5- (2-oxo-3-methyloxazolidine), as described in example 1, step C.  After recrystallization of the crude product from ethyl acetate, 1.17 g of pure product is obtained which melts at 228-229 ° C; Oc 20 „-79 (s-0.5, chloroform).   P. p and me 20.  Z-oxr-5-3.  19-CyCloandrost-6-en-175-5- (2-oxo-3-methyloxazolidine).  9 K. stirring a suspension of 5.30 g of chromium-pyridine trioxide complex in 80 ml of dry dichloromethane was added dropwise at room temperature a solution of 0.85 g of 3-fi hydroxy-5p.  . 19-cycloandrost-6-en-175-spiro-5- (2-oxo-3-methyloxazvlidine; obtained in accordance with example 19, in 18 ml of dry dichloromethane.  The reaction mixture is stirred for 20 hours and then filtered.  The dichloromethane solution is shaken with water, dried and passed through a neutral alumina slurry.  Then the solution is evaporated and the resulting dry residue is recrystallized from ethyl acetate, resulting in a yield of 0.50 g of pure compound with m. square  164 ° C; , 5 ° (, 5, chloroform).  Example 21  Ent.  13 | -ethylgone-4-in-3-on-17S: thio-5- (2-ox-3-methyloxazolidine).  Stage L.  in accordance with the procedure described in example 11, method A, stage A, based on ent. 13-ethyl-3-methoxy-2, 5 {1O) -diene-17-one, get ent. 13-ethyl-3-methoxygon-2,5 (10) diene-1 75-spirooxirane. T. square   C, Mo-109 (, 5, chloroform).  Stage B.  Znt  The 13p-ethyl-3-methoxygon-2.5 (10) diene-17S-spirooxyran obtained in step A is reacted with methyl as described in example 11, method A, step B, and the resulting product is then converted to the corresponding N -spiroporan, arbitrary according to the procedure described in example 11, method A, stage C.  Turning this compound according to Example 11, Method A, Step D, results in an ent.  1Ps-ethyl-3-methoxygon-2.5 (10) -diene, 75-spiro-5CH2-oxo-3-methyloxazolidine) with t. square  208 ° С; Сос12 ° -19 ° (, 5, chloroform).  Stage C.  Ent.  13-ethyl-3-methoxy-2,5-2,5 (10) -diene-175-spiro-5- (2-oxo-3-methyloxazolidine) is hydrolyzed with hydrochloric acid in an aqueous methanol solution, as described in Example 12, with the result that get an ent. 13 (9-ethyl-en-3-one-175-spiro-5- (2oxo-3 methyloxazolidine 191 C, 3j + (, 5, chloroform).  Example 22, 13 -Etil-Zoxyminogon-1-ene-175-spiro-5- (2-oxo-3-methyloxazolidine).  Method A.  A solution of 0.9, g 13 | ethyl ethyl-en-3 oi-1 75-spiro-5- (2-oxo-3 methyl zxazolidine), 0.2 g of hydroxylamine hydrochloride and 0.25 g of dry sodium acetate in a mixture of 3 ml of water and 20 ml of ethanol t in a water bath for one mas.  The reaction mixture is evaporated, the crystalline residue is washed, dried and recrystallized from methanol, the result is 0.50 g of product with m. square  28: 286 ° C; M -H86 (, 5, chloroform Method B, Solution 1 g 13 (L-ethyl-3-methoxygon-2, 5 (TO) -diene-175-spiro-5- (2-oxo- 3-methyloxazolidine) and 1 g of hydroxylamine chlorohydrate in 10 ml of dry pyridine are stirred at 50 ° C for 0.5 h and at 80 ° C for an additional hour.  The reaction mixture is evaporated.  The residue is dissolved in chloroform and then the solution is shaken with 2, an aqueous solution of hydrochloric acid, then with a saturated solution of sodium bicarbonate and with water.  The chloroform solution is dried and evaporated.  After recrystallization of the residue from methanol, 0.5 g 13 (L-ethyl-3-oximinogon-4-ene-17S-spiro-5- (2-oxo-3-methyloxazolidine) is obtained, which melts at 283 ° C; jJ + 70 ° ( 5, chloroform).  Oximes, obtained by methods a and B. Are mixtures of 2- and E-isomers in different ratios.  Example 23  13-ethyl-3 methyuxyminogong1 + -en-1 75-spiro-5- (2oxo-3-methyloxazolidine), In accordance with the procedure described in example 22, method A, using O-methylhydroxylamine chloromatmrate, and continuing the reaction for 5 hours, obtain the desired compound which, after recrystallization from ethyl acetate, melts at 180-182 ° C; oC   85 (, 5, chloroform).  Example 24  13p- Ethyl-3-apliloximinogon-4-ene-175-spiro-5- (2-oxo-3-methyloxazolidine).  In accordance with the procedure described in Example 22, Method A, using O-allylhydroxylamine hydrochloride, the desired compound is obtained.  square  I after recrystallization.  FROM methane-ol 'T3S-165C; + 73 ° (, 5, chloroform).  PRI me R 25.  3 0 xmino-androst-, 6-di-17S-spiro-5- (2-ox-3-methyloxazolidine).  Starting from 7.1 g of androst-, 6-dien-3-one-175pyro-5- (2-oxo-3-methyloxazolidine) prepared in Example 8, and according to the method described in Example 22, step A, 7 are obtained. , 5 g of crude product, which is recrystallized from ethanol.  T. square   C (decomposition).  LOC -57.3 ° (, in chloroform).  PRI me R 26.  ir-ethyl-3 oximino-6a-, 9 (10), 11-triene-175spiro-5- (2-oxo-3-methyloxazolidine).  Outcome of 1.77 g of 13p-ethylgon-, 9 (10), 11triei-3-one-175-spiro-5- (2-oxo-Zmethyloxazolidine) prepared according to Example 16, and according to the method described in Example 22, step A, a crude product (1.88 g) is obtained, which is recrystallized from ethyl acetate.  Yield 1.55 g; t. square  273-275С (decomposition) iM2j ° -108 ° (in chloroform).  Claim 1.  The method of producing steroid spirooxazolidines of the general formula.  where alkyl with 1 carbon atoms; R, - V9DOROD, alkyl with I - carbon atoms, alkenyl with 2 - carbon atoms; Z is one of the groups represented by general formulas.
nineteen
R.J is hydrogen or methyl;
 fluorine, hydroxyl, acyloxy with 2-3 carbon atoms, alkoxycarbonyloxy with 2-carbon atoms, oxo group, oxyimino group or alkoxyimino group with 1-3 carbon atoms;
3110920
 an oxo group, an oximino group, or an alkoxy amino group with 1 to 3 carbon atoms; alkyl with 1 to 3 carbon atoms
or their stereoisomers, characterized in that the compound of the general formula C:
but snging
"Y
where R, Rrt and Z are as defined;
RY is an alkoxycarbonyl group with carbon atoms, is cyclized in the presence of a base, preferably an alkali or alkali metal alcoholate or ketone, followed by isolation of the target product;
Sources of information taken into account in the examination 1. Heterocyclic compounds. Ed. L. Elderfield. V. 5, 19b7, p. 312.

类似技术:

---

公开号 | 公开日 | 专利标题

---

SU695560A3|1979-10-30|Method of preparing spirolactones

---

SU1052161A3|1983-10-30|Process for preparing derivatives of thioethyanic acid

---

CA1150238A|1983-07-19|Synthesis of steroids

---

US4006172A|1977-02-01|Process for 7-keto-Δ5 -steroids

---

SU931109A3|1982-05-23|Process for producing steroid spirooxazolidines or their stereoisomers

---

EP0326340A2|1989-08-02|Improvement in the synthesis of 6-methylene derivatives of androsta-1,4-diene-3,17-dione

---

KOYAMA et al.1983|Thermolysis of oxime O-allyl ethers: A new method for pyridine synthesis

---

PL185112B1|2003-02-28|Method of obtaining the ketal derivative of a steroid

---

CA1255294A|1989-06-06|Antiandrogenic sulfonylsteroidopyrazoles andprocesses for preparation, method of use andcompositions thereof

---

DK162448B|1991-10-28|METHOD FOR PREPARING 17BETA-HYDROXY-3-OXO-17ALFA-PREGN-4-EN-21-CARBOXYLIC ACID DELTA-LACTON OR 17BETA-HYDROXY-3-OXO-17ALFA-PREGNA-4,6-DIENE-4,6-DIENE lactone

---

US3280133A|1966-10-18|-2-aza-5alpha-androstan-17beta-ols and acyl derivatives thereof

---

El‐Rayyes et al.1977|Acetylenic ketones. Part IV. Reaction of p‐nitrobenzoylphenylacetylene with nucleophilic nitrogen compounds

---

Ogura et al.1965|The Reaction of Aminotropones with Diketene. I. On the Synthesis of 3-Acetyl-1-azaazulenes and Related Reactions

---

Cremlyn et al.1981|Some heterocyclic sulfonyl chlorides and derivatives

---

HU185639B|1985-03-28|Process for preparing 17alpha-hydroxy-20-oxo-steroids

---

SU772483A3|1980-10-15|Method of preparing 6a, 10a-cis-hexahydrodibenzopyran derivatives

---

US5905153A|1999-05-18|Process for preparing |-1-|alkanones

---

US3723483A|1973-03-27|11{62 -methyl-17{60 -propadienyl steroids

---

US4145357A|1979-03-20|Steroid derivatives and process for preparing the same

---

US3196161A|1965-07-20|Process for preparing alkyl 3-alkyl-isoxazole-5-carboxylate

---

US6498276B2|2002-12-24|Process for producing acetophenone compound

---

US3178408A|1965-04-13|Aminosteroid compounds and process for their manufacture

---

MX2008013408A|2008-11-12|2-alkenyl-3-aminothiophene derivative and method for producing the same.

---

HU214086B|1997-12-29|Process for producing 3-isoxazolecarboxylic acid and intermediates thereof

---

JP2512388B2|1996-07-03|Intermediates for the production of sometimes tritiated 16-imino-17-azasteroids

同族专利:

---

公开号 | 公开日

---

SE7802666L|1978-09-15|

---

ATA175378A|1982-07-15|

---

GB1599464A|1981-10-07|

---

AU3383478A|1979-09-06|

---

DK111578A|1978-09-15|

---

AT370113B|1983-03-10|

---

FI780772A|1978-09-15|

---

DE2811101A1|1978-10-19|

---

JPS53116372A|1978-10-11|

---

NL7802784A|1978-09-18|

---

FI65264C|1984-04-10|

---

IL54169D0|1978-06-15|

---

FR2383970B1|1981-12-04|

---

AU522931B2|1982-07-01|

---

ES467861A1|1978-10-16|

---

HU179711B|1982-11-29|

---

BE864689A|1978-09-11|

---

CH639399A5|1983-11-15|

---

IL54169A|1981-12-31|

---

FI65264B|1983-12-30|

---

SU915806A3|1982-03-23|

---

JPS6050199B2|1985-11-07|

---

US4180505A|1979-12-25|

---

CA1115691A|1982-01-05|

---

FR2383970A1|1978-10-13|

---

NO780867L|1978-09-15|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US3272801A|1964-11-19|1966-09-13|American Home Prod|Steroidal spiro-oxazolidinones|

---

NL7107998A|1970-07-09|1972-01-11|

---

HU167833B|1973-07-09|1975-12-25|

---

US4018774A|1976-02-13|1977-04-19|E. R. Squibb & Sons, Inc.|Steroidal [16α,17-d]isoxazolidines|HU178397B|1978-04-01|1982-04-28|Gyogyszerkutato Intezet|Process for preparing substituted derivatives of steroid-spiro-oxazolidione derivatives|

---

HU179980B|1979-12-28|1983-01-28|Gyogyszerkutato Intezet|Process for preparing substituted steroid-spiro-oxazolidinone derivatives|

---

HU181066B|1980-03-12|1983-05-30|Gyogyszerkutato Intezet|Process for preparing steroid -spiro-oxathiazolidine derivatives|

---

US4460509A|1981-08-19|1984-07-17|Beth Israel Medical Center|Chemical synthesis|

---

US7214825B2|2003-10-17|2007-05-08|Honeywell International Inc.|O- hydroxylamine free base|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

HU77GO1364A|HU179711B|1977-03-14|1977-03-14|Process for preparing steroid-spiro-oxazolidinone derivatives|

---